T1	p 77 122	treated hypertensive patients . Collaborative
T2	p 275 332	hypertensive patients receiving drug treatment , but data
T3	p 562 578	chronic , stable
T4	p 785 1085	people with one or more cardiovascular risk factors . Fifteen Italian hypertension units studied 142 hypertensive patients ( 76 men , 66 women ; mean age 59 +/- 5.9 years ) treated with different antihypertensive drugs : 71 patients were randomized to aspirin and 71 served as controls . All patients
T5	p 1154 1245	and a 24-h ambulatory BP monitoring , at baseline and after 3 months of aspirin treatment .
T6	p 1940 1953	hypertensives
T7	i 17 33	low-dose aspirin
T8	i 109 122	Collaborative
T9	i 193 230	. Nonsteroidal antiinflammatory drugs
T10	i 360 367	aspirin
T11	i 449 474	of aspirin ( 100 mg/day )
T12	i 761 781	aspirin or vitamin E
T13	i 981 1003	antihypertensive drugs
T14	i 1037 1058	aspirin and 71 served
T15	i 1062 1072	controls .
T16	i 1098 1245	clinic BP evaluation with an automatic sphygmomanometer and a 24-h ambulatory BP monitoring , at baseline and after 3 months of aspirin treatment .
T17	i 1414 1421	aspirin
T18	i 1681 1688	aspirin
T19	i 1769 1779	inhibitors
T20	i 1784 1803	calcium antagonists
T21	i 1915 1922	aspirin
T22	o 44 73	and ambulatory blood pressure
T23	o 242 263	blood pressure ( BP )
T24	o 478 541	clinic and ambulatory systolic ( SBP ) and diastolic ( DBP ) BP
T25	o 1105 1107	BP
T26	o 1282 1303	in clinic SBP and DBP
T27	o 1373 1395	Ambulatory SBP and DBP
T28	o 1926 1936	BP control